Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Poster Presentations,Highlighting Mechanism of Action and Clinical Activity of,Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American,Diabetes Association 67th Scientific Sessions in Chicago, Illinois

rest include: 2220 - Oral Administration of Sulodexide for the Treatment of Diabetic Nephropathy in a Phase II Study has Minimal to No Effect on Coagulation or Fibrinolytic Activity JULIA LEWIS, ITAMAR RAZ, SHERWYN SCHWARTZ, STEPHEN ARONOFF, MURRAY KATZ, GILBERT EISNER, JAMES MERSEY, Nashville, TN, Jerusalem, Israel, San Antonio, TX, Dallas, TX, Tucson, AZ, Washington, DC, Baltimore, MD 2376 - Efficacy and Safety of Sulodexide in the Treatment of Diabetic Nephropathy RAM WEISS, ROBERT M. NIECESTRO, ITAMAR RAZ, Jerusalem, Israel, New York, NY

ABOUT SULONEX(TM)

Sulonex (sulodexide oral gelcap) belongs to a proposed new class of nephroprotective, or kidney protecting, drugs, known as the glycosaminoglycans. A variety of members of this chemical family have been shown to decrease pathological albumin excretion in diabetic nephropathy in humans. Some of the members of this chemical family include the following approved drugs: standard heparin, low molecular weight heparin and danaparoid. These agents all require therapy by injection and are all potent anticoagulants, which are blood thinners capable of inducing bleeding. Sulonex, on the other hand, is given orally and, in this form, has demonstrated little, if any, anticoagulant effects to date.

Keryx owns the exclusive rights to use Sulonex(TM) for the treatment of diabetic nephropathy in North America, Japan and certain other markets outside of Europe. Diabetic nephropathy is a long-term complication of diabetes in which the kidneys are progressively damaged. Sulonex is a glycosaminoglycan compound with structural similarities to the broad family of marketed heparins and low molecular weight heparins. This drug has been marketed in a number of European, Asian and South American countries for many years by our licensor for certain cardiovascular conditions and has an established safety profile at
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:4/21/2015)... April 21, 2015  St. Vincent Healthcare is ... care. Already following strict disinfection routines, St. Vincent ... to eliminate harmful germs, like Ebola, methicillin-resistant ... that can infect patients during their hospital stay. ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
(Date:4/21/2015)... , April 21, 2015   iRhythm Technologies, ... the advancement of cardiac care, announced today that Banner ... in the U.S., will now be offering iRhythm,s ZIO ... continuous cardiac monitoring. "At Banner Health, we ... patient outcomes and services," said John Hensing , ...
(Date:4/21/2015)... 21, 2015 Workers, compensation pharmacy spending increased ... in utilization helped offset a 7 percent increase in ... today by Express Scripts (NASDAQ: ESRX ). ... Trend Report discusses the overall pharmacy trend as well ... Opioid Management Mitigates Spend Increases ...
Breaking Medicine Technology:St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 2Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 3Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs 4
... 10, 2011 ThermoGenesis Corp. (Nasdaq: KOOL ... that process and store adult stem cells, said today ... Biotechnology Co., Ltd ("Beike"), a leading stem cell and ... agreement, ThermoGenesis will supply Beike with an initial stocking ...
... The Consumer Healthcare Products Association (CHPA) is pleased to ... Act, introduced today by Senator Kay Bailey Hutchison (R-Tex.) ... repeal a requirement enacted into law as part of ... that requires consumers to obtain a prescription in order ...
Cached Medicine Technology:ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company 2ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company 3ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company 4CHPA Applauds Introduction of The Patients' Freedom to Choose Act 2
(Date:4/21/2015)... QuickMedical, a veteran-owned leader in the ... Schiller America's line of Ambulatory and ... Vital Signs Monitors, among many other items. ... leader in the development and production of cardio-pulmonary ... cooperation with the world's leading physicians and specialists ...
(Date:4/21/2015)... Respected academic institution selects Visage 7 for ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro ... contract with University of Florida Health — a large ... furthers the penetration of Visage 7 technology ... the North American enterprise imaging market. Visage 7 ...
(Date:4/21/2015)... 21, 2015 Approximately 75 million Americans ... U.S. Environmental Protection Agency (EPA). On top of this, ... smoke increase the level of toxins found in the ... these harmful toxins is to increase consumption of broccoli. ... highest level of glucoraphanin – a long-lasting antioxidant – ...
(Date:4/21/2015)... 21, 2015 Health Advocate™, Inc., the ... subsidiary of West Corporation, is hosting a complimentary webinar ... and the benefits of offering this service to employees. ... for managing their healthcare, it is critical that they ... effectively utilize their health benefits. Health advocates can play ...
(Date:4/21/2015)... Le Petit Retreat Day Spa in L.A. is no ... leafy, historic Larchmont neighborhood, newly renamed as the Larchmont Sanctuary ... “Disconnect to Reconnect.” Tina Figueroa, a former tech exec ... announces the new name and new vision for the spa, ... celebrate connections with Moms and their adult children. , ...
Breaking Medicine News(10 mins):Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Health Advocate Webinar Discusses Benefits of Health Advocacy 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3
... on First-line ART; Advocates Press,for Second-line Access, ... is,being issued by AIDS Healthcare Foundation (AHF):, ... improve access to lifesaving,AIDS treatments worldwide, AIDS Healthcare ... India as AHF/India Cares, and a broad-based,coalition of ...
... - No Human Vaccine Currently Exists Against the West ... in the US so far in 2007;,Collaboration Aims to ... Rapidly as Possible Acambis plc (Acambis) (LSE: ACM), ... signed an exclusive global,collaboration agreement with Sanofi Pasteur, the ...
... carbohydrates may help stunt the growth of prostate tumors, according ... The study, in mice, suggests that a reduction in insulin ... , This study showed that cutting carbohydrates may slow tumor ... urologist at Duke University Medical Center and lead researcher on ...
... 12 Beckman Coulter,Inc. (NYSE: BEC ), ... simplify, automate, and innovate complex biomedical testing,announced today ... chief financial officer, will present at the 2007 ... 2007, at,11:00 a.m. (ET). (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ...
... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), the ... hospitals throughout the United States,today announced that it ... Conference, November 28, 2007, at 2:30 p.m. EST ... Mayleben, President and Chief Operating,Officer, and Glenn Cole, ...
... Nov. 12 IRIDEX,Corporation (Nasdaq: IRIX ) today ... results after the market closes on Monday, November,19, 2007. ... a,conference call with the investment community at 5:00 p.m. ... results of the quarter and other,business developments. Interested ...
Cached Medicine News:Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 2Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 3Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 4Health News:Activist Groups' Plea to Indian Prime Minister: 'Rollout Second-Line AIDS Treatment!' 5Health News:Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine 2Health News:Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine 3Health News:Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine 4Health News:A low-carb diet may stunt prostate tumor growth 2Health News:Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference 2Health News:NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: